| Article 1 |
|
| Article 2 |
|
| Article 3 |
An OTC company to which any circumstance set forth in any subparagraph of Paragraph 1 of the preceding article applies, or that discovers mass media reportage of any circumstance set forth in any subparagraph of the preceding article or mass media reportage that diverges from fact, shall handle those of such cases conforming to the circumstances set forth in any subparagraph of Paragraph 1 of Article 2 of the GreTai's Procedures for Press Conferences Concerning Material Information of OTC Companies in compliance with Article 5 of said Procedures, and shall handle all other such cases by inputting the content or explanations of the information into the Internet information reporting system designated by the GreTai before the commencement of trading hours of the trading day next following the date of occurrence of the event (date of agreement, date of contract signing, date of payment, date of execution of a trading order, date of title transfer, date of resolution of the board of directors or a committee established thereby, or other date that can confirm the counterpart and monetary amount of the transaction, whichever date is earlier, or for an investment requiring the approval of the Competent Authority, the earliest of such dates or the date of receipt of approval from the Competent Authority) or date of the media reportage; provided, where a press release is issued prior thereto, it shall be input at the time of issuance of the press release. Where foreign laws or regulations impose time constraints concerning material information that an OTC company is required to report on behalf of a foreign enterprise under these Procedures, the OTC company may accommodate the time constraints on the foreign enterprise and make the disclosure simultaneously therewith.
Where an OTC company has issued securities overseas, if any circumstance in paragraph 1 of the preceding article applies to the company during the duration of those securities, the company shall simultaneously input the content or explanations of the information in English into the Internet information reporting system designated by the GreTai, or if it experiences any material event that requires immediate filing under the government laws and regulations, or securities exchange market rules, of the country where the securities are listed, it shall simultaneously input such information into the Internet information reporting system designated by the GreTai, and if it receives any written enquiry from a securities regulatory agency or securities exchange of that country with respect to any matter that has a material effect on shareholders' equity or the price of securities, it shall immediately forward a copy of the content of the written enquiry and any response thereto to the GreTai.
An OTC company may not convene an investor/press conference, or publicly disclose any financial or business information relating to an investor/press conference, during the intraday session, nor may it provide any related information to any specific person in advance. If the need arises to convene an overseas investor/press conference during the intraday session, such cases shall be reported to the GreTai in advance for approval on a special case-by-case basis. |
| Article 4 |
|
| Article 5 |
|
| Article 6 |
|
| Article 7 |
|
| Article 8 |
|
| Article 9 |
|
| Article 10 |
|